GUJARAT THEMIS BIOSYN
Quarterly Results Analysis [Sep2024]
GUJARAT THEMIS BIOSYN Quarterly Results
Standalone | Sep2024 Audited |
Jun2024 UnAudited |
Mar2024 Audited |
Dec2023 Audited |
Sep2023 Audited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹35 Cr | ₹39 Cr | ₹42 Cr | ₹39 Cr | ₹40 Cr | ₹50 Cr | ₹28 Cr | ₹28 Cr |
Expenses | ₹19 Cr | ₹20 Cr | ₹21 Cr | ₹21 Cr | ₹23 Cr | ₹26 Cr | ₹13 Cr | ₹16 Cr |
Operating Income | ₹15 Cr | ₹19 Cr | ₹21 Cr | ₹18 Cr | ₹17 Cr | ₹24 Cr | ₹14 Cr | ₹12 Cr |
Other Income | ₹0 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Profit Before Tax | ₹14 Cr | ₹18 Cr | ₹21 Cr | ₹18 Cr | ₹17 Cr | ₹24 Cr | ₹16 Cr | ₹13 Cr |
Profit After Tax | ₹11 Cr | ₹13 Cr | ₹16 Cr | ₹13 Cr | ₹13 Cr | ₹18 Cr | ₹12 Cr | ₹10 Cr |
EPS | ₹0.97 | ₹1.21 | ₹1.46 | ₹1.19 | ₹1.15 | ₹1.63 | ₹1.07 | ₹0.90 |
Industry Peers & Returns | 1W | 1M | 1Y |
GUJARAT THEMIS BIOSYN | 3% | -11.3% | 27.9% |
SUN PHARMACEUTICAL INDUSTRIES | 0.6% | -2.1% | 16.5% |
CIPLA | 3.6% | 0.2% | 2.3% |
DR REDDYS LABORATORIES | 3% | -8.4% | 0% |
ZYDUS LIFESCIENCES | 3.2% | -1% | 27.4% |
DIVIS LABORATORIES | 4.3% | 6.5% | 63.9% |
MANKIND PHARMA | -2.5% | -8% | 16.5% |
TORRENT PHARMACEUTICALS | 2.9% | -0.5% | 19.4% |
LUPIN | 8.2% | 0.4% | 37% |
GUJARAT THEMIS BIOSYN Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -10.59 % |
Y-o-Y | -12.21 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Sep2024 | ₹35 Cr | -10.59 | |
Jun2024 | ₹39 Cr | -7.58 | |
Mar2024 | ₹42 Cr | 8.11 | |
Dec2023 | ₹39 Cr | -1.73 | |
Sep2023 | ₹40 Cr | -20.25 | |
Jun2023 | ₹50 Cr | 79.76 | |
Mar2023 | ₹28 Cr | -2.06 | |
Dec2022 | ₹28 Cr | - |
GUJARAT THEMIS BIOSYN Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -17.03 % |
Y-o-Y | -7.97 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Sep2024 | ₹15 Cr | -17.03 | |
Jun2024 | ₹19 Cr | -11.37 | |
Mar2024 | ₹21 Cr | 17.95 | |
Dec2023 | ₹18 Cr | 6.10 | |
Sep2023 | ₹17 Cr | -28.85 | |
Jun2023 | ₹24 Cr | 63.67 | |
Mar2023 | ₹14 Cr | 18.59 | |
Dec2022 | ₹12 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -7.22 % |
Y-o-Y | 4.82 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Sep2024 | 44.33% | -7.22 | |
Jun2024 | 47.78% | -4.09 | |
Mar2024 | 49.82% | 9.09 | |
Dec2023 | 45.67% | 7.99 | |
Sep2023 | 42.29% | -10.78 | |
Jun2023 | 47.4% | -8.95 | |
Mar2023 | 52.06% | 21.07 | |
Dec2022 | 43% | - |
GUJARAT THEMIS BIOSYN Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -20.17 % |
Y-o-Y | -15.75 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Sep2024 | ₹11 Cr | -20.17 | |
Jun2024 | ₹13 Cr | -16.68 | |
Mar2024 | ₹16 Cr | 22.09 | |
Dec2023 | ₹13 Cr | 3.74 | |
Sep2023 | ₹13 Cr | -29.22 | |
Jun2023 | ₹18 Cr | 51.58 | |
Mar2023 | ₹12 Cr | 19.21 | |
Dec2022 | ₹10 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -10.71 % |
Y-o-Y | -4.04 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Sep2024 | 30.44 % | -10.71 | |
Jun2024 | 34.09 % | -9.84 | |
Mar2024 | 37.81 % | 12.90 | |
Dec2023 | 33.49 % | 5.58 | |
Sep2023 | 31.72 % | -11.25 | |
Jun2023 | 35.74 % | -15.67 | |
Mar2023 | 42.38 % | 21.71 | |
Dec2022 | 34.82 % | - |
GUJARAT THEMIS BIOSYN Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -19.83 % |
Y-o-Y | -15.65 % |
Quarters | EPS | % Change | |
---|---|---|---|
Sep2024 | ₹0.97 | -19.83 | |
Jun2024 | ₹1.21 | -17.12 | |
Mar2024 | ₹1.46 | 22.69 | |
Dec2023 | ₹1.19 | 3.48 | |
Sep2023 | ₹1.15 | -29.45 | |
Jun2023 | ₹1.63 | 52.34 | |
Mar2023 | ₹1.07 | 18.89 | |
Dec2022 | ₹0.9 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD